health 🩺 Non-surgery options for early rectal cancer show promise
A large randomized study revealed that almost 80% of early-stage rectal cancer patients avoided surgery for over a year using chemoradiation therapy. This was found in patients across various locations, as reported by researchers led by Simon Bach of University College London. Specifically, 78.5% of those randomized to CRT remained surgery-free at 12 months. This suggests a response-adapted organ-preservation strategy offers better 12-month outcomes with CRT. Longer follow-up is still necessary to fully assess long-term cancer control and safety. 🩺